Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 October 2025 | Story Lacea Loader

The University of the Free State (UFS) Executive Committee (Exco), Institutional Representative Council (ISRC), and Campus Student Representative Councils (CSRCs) of the three campuses met on 15 October 2025 and reached an agreement regarding the implementation of the phasing out of provisional registration. 
The discussions were held in light of the decision made by the UFS Council on 26 September 2025 to phase out the provisional registration – a decision that led to the recent protest actions on the three campuses the past week. 

In a spirit of working towards a fairer, more equitable, and sustainable financial support system for all academically deserving students, Exco and the student leadership agreed that provisional registration will be phased out over a period of two years (2026-2027). This phased approach allows the university time to assess the risks students are facing with a view to assisting students. This means that from 1 January 2026, all students will be on a fully registered system. 

In recognition of the challenges students face, the outcomes of the meeting reflect the university’s ongoing commitment, and it ensures that all students are supported within a financially sustainable framework. It also reaffirms the university’s commitment to expanding access through enhanced financial support while sustaining the UFS as a national asset for future generations. 

The Exco remains committed to ongoing engagement with student leadership through open dialogue that reflects the university’s values, appreciates the constructive approach taken by the student leadership, and remains dedicated to working collaboratively in the best interest of all students and the broader university community.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept